HEA 3071 Module 2 Atherosclerosis Case Study: Plaque, Inflammation and Myocardial Infarction Example

Fire in the Artery Wall: Inflammation and a Heart Attack in a Retired Firefighter

Student Name

B.S. in Health Studies, Thomas Edison State University

HEA-3071: Pathophysiology for Health Professionals

Mentor Name

Month Day, Year

Fire in the Artery Wall: Inflammation and a Heart Attack in a Retired Firefighter

The Patient

Frank is invented for this case. He is 61, retired after thirty years with the Kearny fire department and smoked a pack a day until five years ago. He takes medicine for high blood pressure but stopped his cholesterol pill because of muscle aches. At 5 a.m. he woke with heavy pressure behind his breastbone that ran down his left arm, with sweating and nausea. In the emergency department his electrocardiogram showed ST depression in the lateral leads, and his high-sensitivity troponin rose from a value near the upper reference limit to many times higher over three hours. A catheterization showed a ruptured plaque with a clot partly blocking a branch of the left coronary artery.

The Normal Artery

A healthy artery has a smooth inner lining of endothelial cells that release nitric oxide, which relaxes the vessel, prevents platelets from sticking and limits inflammation. Beneath the lining lies a layer of smooth muscle that controls the vessel's diameter. Blood flows smoothly, and clots form only where the lining is injured.

How Plaque Forms

Libby et al. (2011) described atherosclerosis as a chronic inflammatory disease of the artery wall. It begins when low-density lipoprotein particles enter the wall at sites of disturbed flow and become modified. The endothelium expresses adhesion molecules that capture circulating monocytes, which enter the wall and become macrophages. Macrophages take up modified lipoprotein and become foam cells, forming a fatty streak. Inflammatory signals, including cytokines such as interleukin-1 beta, recruit more cells and stimulate smooth muscle cells to migrate and form a fibrous cap over a core of lipid and dead cells. Over decades, the plaque grows. Smoking, high blood pressure, diabetes and high cholesterol all speed this process by injuring the endothelium or adding to the lipid supply.

How a Plaque Causes a Heart Attack

Most heart attacks do not come from the largest plaques but from plaques with thin caps and large lipid cores. Inflammatory cells release enzymes that weaken the cap. When the cap ruptures, or when the surface erodes, the blood meets tissue factor and other material that triggers clotting. Platelets gather and a clot forms, narrowing or blocking the artery. Heart muscle beyond the blockage is starved of oxygen and begins to die within minutes, releasing troponin into the blood.

Defining Myocardial Infarction

Thygesen et al. (2018) set out the fourth universal definition. Myocardial injury is present when cardiac troponin exceeds the 99th percentile upper reference limit. Myocardial infarction requires acute injury, shown by a rise or fall in troponin, plus signs that the injury came from ischemia: symptoms, new electrocardiogram changes or imaging findings. Type 1 infarction is caused by plaque rupture or erosion with clot. Type 2 infarction results from a mismatch between oxygen supply and demand, for example during severe anemia or a very fast heart rate, without plaque rupture.

Inflammation as a Target

If inflammation drives atherosclerosis, blocking it should reduce events. Ridker et al. (2017) tested this in the CANTOS trial, which enrolled more than 10,000 patients with a prior heart attack and blood tests showing persistent inflammation on high-sensitivity C-reactive protein. Canakinumab, an antibody against interleukin-1 beta, given every three months at the 150 mg dose, reduced repeat heart attacks, strokes and cardiovascular deaths by about 15 percent compared with placebo, without lowering cholesterol. It also caused more fatal infections. The drug was not approved for this use, but the trial confirmed that inflammation is a cause, not only a marker, of cardiovascular events.

Matching Treatment to Mechanism

Frank's treatment acts at each step. Aspirin and a second antiplatelet drug prevent platelets from building the clot. A stent opened the artery. A high-intensity statin lowers low-density lipoprotein, reducing the lipid supply to plaques, and also has anti-inflammatory effects that may stabilize caps. A beta blocker lowers the heart's oxygen demand. His clinician discussed a different statin or dose to avoid muscle aches and referred him to cardiac rehabilitation, where supervised exercise, diet advice and support against smoking relapse continue the work of the drugs.

Occupational and Lifespan Factors

Firefighters face particular heart risks: sudden heavy exertion, heat, smoke and disrupted sleep. Cardiovascular events are a leading cause of on-duty deaths among firefighters. Frank's years of smoking added to these exposures. Atherosclerosis begins in youth, with fatty streaks found in many adolescents, so prevention across the lifespan matters.

Why Risk Factors Speed the Process

Each of Frank's risk factors acts on a step in plaque biology. Smoking injures the endothelium directly, reduces nitric oxide, oxidizes low-density lipoprotein and makes platelets stickier. High blood pressure stresses the artery wall at branch points, where plaques form first. Diabetes, which Frank does not have, adds sugar-modified proteins that inflame the wall. High low-density lipoprotein supplies the raw material for the lipid core. Stopping his statin removed one of the strongest brakes on the process. Quitting smoking five years ago helped, since platelet and endothelial effects of smoking fade within a few years, but decades of damage remained in the plaques themselves.

Limits

CANTOS tested one antibody at a high cost, with infection risk. The universal definition depends on lab-specific troponin limits. Frank is invented, and his care is described as an illustration.

Conclusion

Frank's heart attack was the end of a process that began decades earlier in his artery walls. Libby and colleagues explain how lipid and inflammation build a plaque, how a thin cap ruptures and how a clot forms. The universal definition classifies his infarction as type 1. CANTOS showed that calming inflammation itself reduces events. His treatment targets each step, from platelets to lipids to the heart's workload.

References

Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347), 317-325. https://doi.org/10.1038/nature10146

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J. J. P., Cornel, J. H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., . . . Glynn, R. J. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119-1131. https://doi.org/10.1056/NEJMoa1707914

Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. (2018). Fourth universal definition of myocardial infarction (2018). Circulation, 138(20), e618-e651. https://doi.org/10.1161/CIR.0000000000000617